Hematology and Oncology

Young-onset esophageal adenocarcinoma presenting at more advanced stages; proportion of advanced stage up from 1975 to 2015

Irinotecan, cetuximab, and vemurafenib improve progression-free survival in BRAF^V600E-mutated colorectal cancer

However, outcomes are not always better than those of average citizens in 12 comparison countries

And age-adjusted rate of drug overdose deaths increased from 20.7 to 21.6 per 100,000 from 2018 to 2019

In children with cancer younger than 16, the estimated incidence of hospital-identified SARS-CoV-2 infection was 3 percent

Current approval of the once-daily tablet indicated for patients who have undergone complete tumor removal

Adenocarcinomas increasing in most early-onset subgroups; carcinoid tumors increasing more steeply in all age groups

Increased risk for breast cancer observed, which was seen for up to two years after discontinuation of oral contraceptives

Phase 3 trial data show 96.7 percent of patients who received Orgovyx achieved and maintained castrate levels of testosterone

Those receiving IPC were more likely to report discussing end-of-life preferences, were less likely to receive chemo at end of life